Fluor Corporation filings document a global engineering and construction issuer through earnings-related Form 8-K reports, proxy materials and material-event disclosures. Recent 8-Ks include results of operations and financial condition, with company measures such as backlog and new awards tied to awarded and in-progress contracts.
Fluor's formal disclosures also cover annual meeting governance and executive-officer matters, including director elections, independent auditor ratification, advisory compensation votes, board leadership changes, officer appointments, consulting agreements and indemnification arrangements. Additional filings record portfolio activity, including the completed sale of its remaining NuScale Power shares and related Regulation FD disclosure.
FLUOR CORP (FLR) officer Alvin Collins reported a proposed sale of 5,712 common shares, with an aggregate market value of $342,720 and an approximate sale date of June 8, 2026. The shares were acquired from FLUOR CORPORATION as restricted stock on February 23, 2017, with payment identified as an equity award. The notice lists December 4, 2025 as the Rule 10b5-1 plan adoption or instruction date.
ROSE MATTHEW K reported acquisition or exercise transactions in this Form 4 filing.
Fluor Corp director Matthew K. Rose reported a compensation-related equity award. He received 3,506 shares of Common Stock, granted as restricted stock units that vested on May 6, 2026, at $0.00 per share. After this grant, he directly holds 99,435 Fluor shares, with no derivative positions reported in this filing.
Fluor Corp director Robert G. Card received an equity award of company stock. On May 6, 2026, he acquired 3,506 shares of Fluor common stock as restricted stock units that vested on that date at no purchase price. Following this compensation-related grant, his direct holdings total 4,164 shares.
FLUOR CORP director Teri P. McClure acquired shares through equity compensation. On May 6, 2026, she received 3,506 shares of common stock at no cost, granted as restricted stock units that vested on that date. Following this award, she directly owns 42,652 common shares.
HACKETT JAMES T reported acquisition or exercise transactions in this Form 4 filing.
FLUOR CORP director James T. Hackett received an equity award of 3,506 shares of Common Stock, granted as restricted stock units that vested on May 6, 2026. After this award, his directly held stake rose to 72,863 shares of Fluor common stock.
In addition to these direct holdings, he also has indirect ownership through several investment limited partnerships, including 20,000 shares held by Hackett 2010 Investment Limited Partnership and 10,000 shares each held by Hackett 2018 and Hackett 1997 Investment Limited Partnerships.
Glatch Lisa reported acquisition or exercise transactions in this Form 4 filing.
Fluor Corp director Lisa Glatch received a stock award of 3,506 shares of Common Stock on May 6, 2026. The award was granted as restricted stock units that vested on that date, with no cash purchase price.
Following this grant-and-vesting event, she directly holds 14,059 shares of Fluor common stock. This is a compensation-related equity award rather than an open-market buy or sell transaction.
EBERHART PAULETT reported acquisition or exercise transactions in this Form 4 filing.
Fluor Corp director Paulett Eberhart received an equity award of 3,506 shares of Common Stock on May 6, 2026. The shares were granted as restricted stock units that vested on that date, reflecting compensation rather than an open-market purchase. Following this grant, Eberhart directly holds 43,380 common shares.
Blankenship Charles P reported acquisition or exercise transactions in this Form 4 filing.
Fluor Corp director Charles P. Blankenship received a grant of 3,506 shares of Common Stock on May 6, 2026. The award was granted as restricted stock units that vested on that date, and no purchase price was paid for the shares.
Following this equity award, Blankenship directly holds 9,146 shares of Fluor common stock. This transaction reflects routine equity compensation for a board member rather than an open-market stock purchase or sale.